Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy
Clinical trial NCT02847091 · COMPLETED
Trial details
- NCT number
- NCT02847091
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-29
- Primary completion
- 2017-11-09
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.